RxDoctor Payments Data

Kenneth Newkirk

Otolaryngology · Washington, DCNPI 1750379020

Payments from drug & device makers

What this record shows

Inspire Medical Systems, Inc. accounts for 81.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $496 and has fallen 91.7% since, to $41 in 2025. That places this record below the midpoint for otolaryngology clinicians in DC, where the typical reported total is $795.

$1,102in general payments, 2019–2025

Across 25 payments — averaging $44.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$895
  • Optinose US, Inc.$147
  • Cook Medical LLC$22
  • Medtronic$16
  • Alk-abello, Inc$11
  • Aerin Medical Inc.$10

What the payments were for

  • Travel & lodging$45041%
  • Food & beverage$65159%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,102 in reported general payments places this provider in the 50th percentile of 41 otolaryngology providers in District of Columbia.

See all otolaryngology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$207,324
Medicare patients
647
Services billed
1,830

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl185$4,041
Fluticasone Propionate227$3,169
Mometasone Furoate14$2,031
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth11$1,140
Omeprazole58$571
Montelukast Sodium36$299
Levothyroxine Sodium34$288
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav28$251
Nystatin14$221
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen24$185
Chlorhexidine Gluconate40$141
Acetaminophen-CodeineAcetaminophen With Codeine22$119
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$110
Mupirocin15$89
Clindamycin Hcl14$62

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →